Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

300 ART kids under the microscope: what scientists hope to learn

NCT ID NCT07278960

Knowledge-focused Sponsor: Kazakhstan's Medical University "KSPH" Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study follows 300 children under age 3 who were conceived through IVF or ICSI. Researchers will measure their growth, brain development, and reproductive health to see if these conception methods have any effects. No new treatments are being tested—the goal is simply to gather information to improve future care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this research could help doctors better monitor and care for children conceived through assisted reproductive technologies.
What could go wrong
This is an observational study, not a treatment trial. It will not directly improve health outcomes, and results may not apply to all ART children.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 300 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2025

Expected to finish

Nov 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population will consist of children under three years of age who were conceived via assisted reproductive technologies (ART) in the Republic of Kazakhstan, along with their biological parents. The research cohort will include children conceived through advanced ART methods - specifically intracytoplasmic sperm injection (ICSI) and frozen embryo transfer (FET) - as well as a comparison group of children conceived via conventional IVF and fresh embryo transfer (Fresh-ET). A total of approximately 300 children (including at least 200 male participants for reproductive health analysis) will be recruited from reproductive medicine centers, pediatric hospitals, and outpatient clinics across Kazakhstan. Medical records of participating mothers will also be used for retrospective data collection regarding conception details, pregnancy course, and perinatal outcomes.

Ages

0 months to 3 years

Sex

Anyone

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: For children: * Born as a result of an ART program (IVF, ICSI, FET, or Fresh-ET). * Age at the time of assessment: from birth up to 36 months. * Availability of complete perinatal and medical documentation, including ART cycle characteristics and neonatal outcomes. * Informed consent provided by parents or legal guardians for participation in the study and for biological sample collection (where applicable). For mothers: * History of pregnancy achieved through ART within the territory of Kazakhstan. * Availability of data on pharmacological treatment before and during pregnancy (e.g., hormonal therapy, antithyroid drugs, vitamins, micronutrients). * Willingness to provide anamnestic and perinatal information, and consent for access to medical records. For fathers (in ICSI subgroup): * Documented infertility factor necessitating ICSI. * Agreement to provide relevant medical history and participate in comparative analyses (e.g., endocrine or reproductive parameters of father-son pairs).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anthropometric characteristics are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Arts syndrome nervous system disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Anthropometric characteristics ART Children Neurological condition Somatic health status Urogenital pathology

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Международный клинический центр репродуктологии Persona

    RECRUITING

    Almaty, 050060, Kazakhstan

More trials for these conditions

Other studies related to the condition(s) this trial covers.